scholarly article | Q13442814 |
meta-analysis | Q815382 |
review article | Q7318358 |
P50 | author | Geert Jan Biessels | Q85341527 |
Priya Palta | Q114358583 | ||
Andrea L Christman | Q64866076 | ||
Felicia Hill-Briggs | Q84786242 | ||
P2093 | author name string | Pegah Touradji | |
P2860 | cites work | Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 | Q21534928 |
Insulin in the brain: there and back again | Q26825385 | ||
Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 | Q27860791 | ||
Sex differences in brain gray and white matter in healthy young adults: correlations with cognitive performance | Q28143309 | ||
Health disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statement | Q28388174 | ||
Standards of medical care in diabetes--2013 | Q29620309 | ||
Cognitive dysfunction and diabetes mellitus | Q30489305 | ||
Type 2 diabetes, cognitive function and dementia: vascular and metabolic determinants. | Q31085708 | ||
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. | Q33302740 | ||
Characteristics of neuropsychological functions in inpatients with poorly-controlled type 2 diabetes mellitus | Q33585803 | ||
Cranial volume, mild cognitive deficits, and functional limitations associated with diabetes in a community sample | Q33603254 | ||
Cognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline? | Q33603286 | ||
Type 2 diabetes mellitus, cognition and brain in aging: A brief review | Q33849810 | ||
Cognitive function and fine motor speed in older women with diabetes mellitus: results from the women's health initiative study of cognitive aging | Q35267007 | ||
Statistics to tell the truth, the whole truth, and nothing but the truth Formulae, illustrative numerical examples, and heuristic interpretation of effect size analyses for neuropsychological researchers | Q35573061 | ||
Assessment practices of clinical neuropsychologists in the United States and Canada: a survey of INS, NAN, and APA Division 40 members | Q35994343 | ||
Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies | Q36311526 | ||
Risk of dementia in diabetes mellitus: a systematic review | Q36345254 | ||
Microstructural white matter abnormalities and cognitive functioning in type 2 diabetes: a diffusion tensor imaging study. | Q36477892 | ||
Diabetes and brain damage: more (or less) than meets the eye? | Q36569427 | ||
The adverse impact of type 2 diabetes on brain volume in heart failure | Q36786697 | ||
Type 2 diabetes and risk of cognitive impairment and dementia | Q36926037 | ||
The influence of subclinical cardiovascular disease and related risk factors on cognition in type 2 diabetes mellitus: The DHS-Mind study | Q37164668 | ||
Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years | Q37261182 | ||
Cognitive dysfunction in patients with type 2 diabetes. | Q37783584 | ||
Diabetes and cognitive dysfunction | Q38017477 | ||
Type 2 diabetes mellitus contributes to cognitive decline in old age: a longitudinal population-based study | Q38420510 | ||
Short-term and long-term memory in elderly patients with NIDDM. | Q38463429 | ||
Psychomotor slowing is associated with distal symmetrical polyneuropathy in adults with diabetes mellitus | Q41141406 | ||
Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies | Q41364742 | ||
Cognitive functioning in elderly persons with type 2 diabetes and metabolic syndrome: the Hoorn study | Q43486040 | ||
Differential neuropsychological test sensitivity to left temporal lobe epilepsy | Q43569957 | ||
A biethnic community survey of cognition in participants with type 2 diabetes, impaired glucose tolerance, and normal glucose tolerance: the New Mexico Elder Health Survey | Q43720011 | ||
Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort | Q44958565 | ||
Effects of improved glycaemic control maintained for 3 months on cognitive function in patients with Type 2 diabetes | Q45118548 | ||
Association of type 2 diabetes with depression, brain atrophy, and reduced fine motor speed in a 60- to 64-year-old community sample | Q45848886 | ||
Sensitivity to brain dysfunction of the Halstead-Reitan vs an ability-focused neuropsychological battery. | Q46028606 | ||
Cognitive decline in adulthood: an 11.5-year follow-up of the Baltimore Epidemiologic Catchment Area study | Q46579295 | ||
Cognitive function in Japanese elderly with type 2 diabetes mellitus | Q47955367 | ||
The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods | Q48093475 | ||
Type-2 diabetes and cognitive function in a non-demented population. | Q48138592 | ||
Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus | Q48247759 | ||
Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes | Q48255137 | ||
A detailed profile of cognitive dysfunction and its relation to psychological distress in patients with type 2 diabetes mellitus. | Q48280355 | ||
ERPs reveal deficits in automatic cerebral stimulus processing in patients with NIDDM. | Q48863817 | ||
Intensive multifactorial treatment and cognitive functioning in screen-detected type 2 diabetes--the ADDITION-Netherlands study: a cluster-randomized trial. | Q50779413 | ||
Type II diabetes in mild cognitive impairment and Alzheimer's disease: results from a prospective population-based study in Germany. | Q51870281 | ||
Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. | Q51977974 | ||
Cognitive function in adults with type 2 diabetes and major depression. | Q52004996 | ||
Circumscribed cognitive dysfunction in middle-aged adults with type 2 diabetes. | Q52023990 | ||
Cognitive test performance among nondemented elderly African Americans and whites. | Q52039380 | ||
Neuropsychological Function in Older Subjects with Non‐insulin‐dependent Diabetes Mellitus | Q52206948 | ||
The impact of diabetes mellitus on cognitive decline in the oldest of the old: a prospective population-based study | Q63437229 | ||
Cognitive assessment in diabetes: the need for consensus | Q73486755 | ||
Diabetes and cognitive performance: a story that is still unfolding | Q83886773 | ||
P433 | issue | 3 | |
P921 | main subject | neuropsychology | Q3872 |
meta-analysis | Q815382 | ||
type 2 diabetes | Q3025883 | ||
cognitive dysfunction | Q57859955 | ||
P304 | page(s) | 278-291 | |
P577 | publication date | 2014-02-20 | |
P1433 | published in | Journal of the International Neuropsychological Society | Q15755321 |
P1476 | title | Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains | |
P478 | volume | 20 |
Q91976011 | A double-blind placebo-controlled clinical trial testing the effect of hyperbaric oxygen therapy on brain and cognitive outcomes of mildly cognitively impaired elderly with type 2 diabetes: Study design |
Q47663822 | Alterations of Brain Energy Metabolism in Type 2 Diabetic Goto-Kakizaki Rats Measured In Vivo by (13)C Magnetic Resonance Spectroscopy. |
Q51760764 | Altered Brain Functional Hubs and Connectivity in Type 2 Diabetes Mellitus Patients: A Resting-State fMRI Study. |
Q36858717 | Analysis of the relationships between type 2 diabetes status, glycemic control, and neuroimaging measures in the Diabetes Heart Study Mind. |
Q89475101 | Association between diabetes and cognitive function at baseline in the Brazilian Longitudinal Study of Adult Health (ELSA- Brasil) |
Q55154216 | Association of ApoE Genetic Polymorphism and Type 2 Diabetes with Cognition in Non-Demented Aging Chinese Adults: A Community Based Cross-Sectional Study. |
Q38823846 | Associations between recent severe hypoglycemia, retinal vessel diameters, and cognition in adults with type 1 diabetes |
Q40766958 | Awareness of Pre-diabetes or Diabetes and Associated Factors in People With Psychosis. |
Q92545350 | Brain microstructural abnormalities in type 2 diabetes mellitus: A systematic review of diffusion tensor imaging studies |
Q38955965 | Cerebrovascular complications of diabetes: focus on cognitive dysfunction |
Q58572568 | Changes in Cerebrospinal Fluid Tau and β-Amyloid Levels in Diabetic and Prediabetic Patients: A Meta-Analysis |
Q51776703 | Cognitive and gait decrements among non-demented older adults with Type 2 diabetes or hypertension: a systematic review. |
Q64882401 | Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. |
Q92669397 | Cognitive dysfunction in diabetes: how to implement emerging guidelines |
Q30902079 | Cognitive function in patients with diabetes mellitus: guidance for daily care. |
Q39166498 | Comorbid Diabetes and Depression in a National Sample of Adults With Psychosis |
Q47151599 | Computerized cognitive training for older diabetic adults at risk of dementia: Study protocol for a randomized controlled trial. |
Q38782819 | Diabetes and Cognitive Decline in Older Adults: The Ginkgo Evaluation of Memory Study |
Q31119662 | Diabetes and Cognitive Impairment |
Q36198644 | Diabetes is Associated with Worse Executive Function in Both Eastern and Western Populations: Shanghai Aging Study and Mayo Clinic Study of Aging |
Q50613713 | Diabetes mellitus and cognitive functioning in a Serbian sample. |
Q64114278 | Disturbed neurovascular coupling in type 2 diabetes mellitus patients: Evidence from a comprehensive fMRI analysis |
Q26783276 | Does Intensive Glucose Control Prevent Cognitive Decline in Diabetes? A Meta-Analysis |
Q36702246 | Dopamine pathway gene variants may modulate cognitive performance in the DHS - Mind Study |
Q37169155 | Early Cognitive Deficits in Type 2 Diabetes: A Population-Based Study. |
Q39362327 | Effects of Exercise on Type 2 Diabetes Mellitus-Related Cognitive Impairment and Dementia. |
Q47797704 | Effects of oxygen-enriched air on cognitive performance during SCUBA-diving - an open-water study. |
Q99711380 | Executive Function and Diabetes: A Clinical Neuropsychology Perspective |
Q38830118 | Exercise for the diabetic brain: how physical training may help prevent dementia and Alzheimer's disease in T2DM patients |
Q42690616 | Feasibility of a multi-modal exercise program on cognition in older adults with Type 2 diabetes - a pilot randomised controlled trial |
Q30845405 | Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review |
Q51760383 | Hippocampal atrophy, asymmetry, and cognition in type 2 diabetes mellitus. |
Q38606226 | Hippocampal insulin resistance and cognitive dysfunction |
Q37540256 | Humans with Type-2 Diabetes Show Abnormal Long-Term Potentiation-Like Cortical Plasticity Associated with Verbal Learning Deficits |
Q57294832 | Impact of a Multidomain Intensive Lifestyle Intervention on Complaints About Memory, Problem-Solving, and Decision-Making Abilities: The Action for Health in Diabetes Randomized Controlled Clinical Trial |
Q30978064 | Impact of diabetes on cognitive function and brain structure. |
Q88626677 | Impact of glycemic status on longitudinal cognitive performance in men with and without HIV infection |
Q53834913 | Increased Plasma Homocysteine Level is Associated with Executive Dysfunction in Type 2 Diabetic Patients with Mild Cognitive Impairment. |
Q38603015 | Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults. |
Q64454287 | Insulin resistance: Genetic associations with depression and cognition in population based cohorts |
Q37658425 | Integrating insulin-like growth factor 1 and sex hormones into neuroprotection: Implications for diabetes |
Q92825513 | Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study |
Q38473620 | Memory and executive functions in persons with type 2 diabetes: a meta-analysis |
Q43705025 | Meta-analyses of clinical neuropsychological tests of executive dysfunction and impulsivity in alcohol use disorder. |
Q89522669 | Neurocognitive impairment in type 2 diabetes: evidence for shared genetic aetiology |
Q38681542 | Neuroimaging and its Relevance to Understanding Pathways Linking Diabetes and Cognitive Dysfunction. |
Q64240263 | Novel Treatment Opportunities Against Cognitive Impairment in Parkinson's Disease with an Emphasis on Diabetes-Related Pathways |
Q55028803 | Pharmacologically induced impairment of neurovascular coupling responses alters gait coordination in mice. |
Q64964666 | Phosphorylated Glycogen Synthase Kinase-3β (GSK-3β) Improves Cognition in Rats with Diabetes-Associated Cognitive Decline. |
Q46155094 | Physical activity and cohabitation status moderate the link between diabetes mellitus and cognitive performance in a community-dwelling elderly population in Germany |
Q39017951 | Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association. |
Q39094966 | Safety and acceptability of an organic light-emitting diode sleep mask as a potential therapy for retinal disease |
Q39914712 | Stability in Test-Usage Practices of Clinical Neuropsychologists in the United States and Canada Over a 10-Year Period: A Follow-Up Survey of INS and NAN Members |
Q92605378 | Sugar in mind: Untangling a sweet and sour relationship beyond type 2 diabetes |
Q37716724 | The Associations among Insulin Resistance, Hyperglycemia, Physical Performance, Diabetes Mellitus, and Cognitive Function in Relatively Healthy Older Adults with Subtle Cognitive Dysfunction |
Q38607661 | The Role of Hyperglycemia, Insulin Resistance, and Blood Pressure in Diabetes-Associated Differences in Cognitive Performance-The Maastricht Study |
Q57175337 | The Therapeutic Potential of Metformin in Neurodegenerative Diseases |
Q88510027 | The impact of cognitive impairment in dementia on self-care domains in diabetes: A systematic search and narrative review |
Q90692981 | Type 2 Diabetes and Cognitive Functions in Middle Age: A Meta-Analysis |
Q35207598 | Type 2 diabetes and cognitive decline over 14 years in middle-aged African Americans and whites: the ARIC Brain MRI Study |
Q39403086 | Type 2 diabetes and cognitive dysfunction in minorities: a review of the literature |
Q95643642 | Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities |
Q33570691 | Type 2 diabetes, depressive symptoms and trajectories of cognitive decline in a national sample of community-dwellers: A prospective cohort study |
Q95643380 | Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective |
Search more.